Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA (2025)
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70117, PubMed 40852937

Nilsen DWT, Leon De La Fuente R, Gallo P, Naesgaard P, Dib Ashur S, Michelsen AE, Aukrust P, Staines H, Ueland T (2025)
Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
Int J Cardiol, 133812 (in press)
DOI 10.1016/j.ijcard.2025.133812, PubMed 40850571

Del Zompo F, Crouchet E, Ostyn T, Nehme Z, Messé M, Juehling F, Désert R, Vieira AT, Moehlin J, Nakib D, Andrews T, Perciani C, Chung S, Bader G, McGilvray I, Caime C, Scaravaglio M, Carbone M, Invernizzi P, Yaqub S, Folseraas T, Karlsen TH, Shankar G, Primeaux M, Dhawan P et al. (2025)
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis
J Hepatol (in press)
DOI 10.1016/j.jhep.2025.08.005, PubMed 40846184

Sudmann TM, Jørstad ØK (2025)
På høy tid med individuell vurdering av kjøreevne
Tidsskr Nor Laegeforen, 145 (9)
DOI 10.4045/tidsskr.25.0413, PubMed 40844342